These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36369631)

  • 1. Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancer.
    Gawish A; Abdullayev N; El-Arayedh S; Röllich B; Ochel HJ; Brunner TB
    Clin Transl Oncol; 2023 Apr; 25(4):987-994. PubMed ID: 36369631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-center retrospective review of metastatic prostate cancer on PSMA position emission tomography/computed tomography: Beyond lymph nodes and bones.
    De Jesus GNC; Pereira V; Karak P; Shearier E
    Prostate; 2025 Jan; 85(1):13-20. PubMed ID: 39295117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline Nodal Status on
    Hofman MS; Kasivisvanathan V; Link E; Buteau J; Roberts MJ; Francis RJ; Tang C; Vela I; Thomas P; Rutherford N; Martin JM; Frydenberg M; Shakher R; Wong LM; Taubman K; Ting Lee S; Hsiao E; Roach P; Nottage M; Kirkwood I; Hayne D; Iravani A; Williams S; O'Brien J; Lawrentschuk N; Murphy DG
    Eur Urol Oncol; 2024 Nov; ():. PubMed ID: 39613566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of rechallenge with [
    Santo G; Di Santo G; Sviridenko A; Bayerschmidt S; Wirth L; Scherbauer F; Lehmann P; von Guggenberg E; Decristoforo C; Heidegger-Pircher I; Bektic J; Virgolini I
    Eur J Nucl Med Mol Imaging; 2024 Dec; 52(1):354-365. PubMed ID: 39225826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography-guided Salvage Radiotherapy Following Prostatectomy.
    Zamboglou C; Staus P; Wolkewitz M; Peeken JC; Ferentinos K; Strouthos I; Farolfi A; Koerber SA; Vrachimis A; Spohn SKB; Aebersold DM; Grosu AL; Kroeze SGC; Fanti S; Hruby G; Wiegel T; Emmett L; Hayoz S; Ceci F; Guckenberger M; Belka C; Schmidt-Hegemann NS; Ghadjar P; Shelan M
    Eur Urol Focus; 2024 Nov; ():. PubMed ID: 39609244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity?
    Mu W; Xu B; Wahafu T; Wang F; Guo W; Zou C; Cao L
    Clin Orthop Relat Res; 2024 Dec; 482(12):2149-2160. PubMed ID: 38991223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSMA PET/CT patterns of recurrence after mono-brachytherapy in men with low and intermediate prostate cancer and subsequent management.
    Loos G; Buteau JP; Oh J; Van Dyk S; Chang D; Murphy DG; Hofman MS; Williams S; Chander S
    Brachytherapy; 2024; 23(6):719-726. PubMed ID: 39358179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [
    Muniz M; Sartor O; Orme JJ; Koch RM; Rosenow HR; Mahmoud AM; Andrews JR; Kase AM; Riaz IB; Belge Bilgin G; Thorpe MP; Kendi AT; Johnson GB; Ravi P; Kwon ED; Childs DS
    J Nucl Med; 2024 Dec; 65(12):1932-1938. PubMed ID: 39477495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Posttherapy 4- and 24-Hour [
    Swiha M; Pathmanandavel S; Papa N; Sabahi Z; Li S; Zheng A; Khan S; Ayers M; Sharma S; Crumbaker M; Nguyen A; Chan L; Ayati N; Emmett L
    J Nucl Med; 2024 Dec; 65(12):1939-1944. PubMed ID: 39477497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen for adults with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quantitative impact of prostate-specific membrane antigen (PSMA) PET/CT staging in newly diagnosed metastatic prostate cancer and treatment-decision implications.
    Abdel-Aty H; Hujairi N; Murray I; Yogeswaran Y; van As N; James N
    BJR Open; 2024 Jan; 6(1):tzae040. PubMed ID: 39606160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort.
    Tariq A; Pearce A; Rhee H; Kyle S; Raveenthiran S; Pelecanos A; Gan CL; Goh JC; Wong D; McBean R; Marsh P; Goodman S; Dunglison N; Esler R; Navaratnam A; Yaxley JW; Thomas P; Pattison DA; Roberts MJ
    Eur Urol Focus; 2024 Sep; 10(5):770-778. PubMed ID: 38195354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for supporting pregnant women's decision-making about mode of birth after a caesarean.
    Horey D; Kealy M; Davey MA; Small R; Crowther CA
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD010041. PubMed ID: 23897547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients.
    Kleiburg F; de Geus-Oei LF; Luelmo SAC; Spijkerman R; Goeman JJ; Toonen FAJ; Smit F; van der Hulle T; Heijmen L
    Eur J Radiol; 2024 Dec; 181():111774. PubMed ID: 39442347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial.
    Swaminath A; Parpia S; Wierzbicki M; Kundapur V; Faria S; Okawara GS; Tsakiridis TK; Ahmed N; Bujold A; Hirmiz K; Owen T; Leong N; Ramchandar K; Filion E; Lau H; Gabos Z; Thompson R; Yaremko B; Mehiri S; Louie AV; Quan K; Levine MN; Wright JR; Whelan TJ
    JAMA Oncol; 2024 Nov; 10(11):1571-1575. PubMed ID: 39298144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid for preventing postpartum haemorrhage after caesarean section.
    Rohwer C; Rohwer A; Cluver C; Ker K; Hofmeyr GJ
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD016278. PubMed ID: 39535297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trial.
    Heinzerling JH; Mileham KF; Robinson MM; Symanowski JT; Induru RR; Brouse GM; Corso CD; Prabhu RS; Haggstrom DE; Moeller BJ; Bobo WE; Fasola CE; Thakkar VV; Pal SE; Gregory JM; Norek SL; Begic XJ; Kesarwala AH; Burri SH; Simone CB
    Lancet Oncol; 2024 Nov; ():. PubMed ID: 39615497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.